Interferon-tau attenuates uptake of nanoparticles and secretion of interleukin-1β in macrophages.
Interferon-tau attenuates uptake of nanoparticles and secretion of interleukin-1β in macrophages.
复制标题
DOI:
10.1371/journal.pone.0113974
复制
发表时间:
2014
期刊:
影响因子:
3.7
通讯作者:
Takahashi M
中科院分区:
文献类型:
--
作者:
Hara K;Shirasuna K;Usui F;Karasawa T;Mizushina Y;Kimura H;Kawashima A;Ohkuchi A;Matsuyama S;Kimura K;Takahashi M
Type I interferons (IFNs), including IFN-alpha (IFNA) and IFN-beta (IFNB), have anti-inflammatory properties and are used to treat patients with autoimmune and inflammatory disorders. However, little is known of the role of IFN-tau (IFNT), a type I IFN produced by ruminant animals for inflammation. Because IFNB has recently been shown to inhibit nucleotide-binding oligomerization domain-like receptor, pyrin domain-containing 3 (NLRP3) inflammasome activation and subsequent secretion of the potent inflammatory cytokine interleukin (IL)-1β, we examined the effects of ruminant IFNT on NLRP3 inflammasome-mediated IL-1β secretion in human THP-1 macrophages. IFNT dose-dependently inhibited IL-1β secretion induced by nano-silica, a well-known activators of NLRP3 inflammasomes, in human macrophages primed with lipopolysaccharide (LPS, TLR4 agonist) and Pam3CSK4 (TLR1/2 agonist). IFNT also suppressed phagocytosis of nano-silica and reactive oxygen species (ROS) generation. Western blot analysis showed that IFNT inhibited both pro-IL-1β and mature IL-1β. In addition, real-time RT-PCR analysis showed that IFNT suppressed IL-1β mRNA expression induced by LPS and Pam3CSK4. Although nano-silica particles did not induce IL-10 secretion, IFNT induced IL-10 secretion in a dose-dependent manner. Furthermore, IFNT-suppressed IL-1β secretion was restored by anti-IL-10 neutralizing antibody. Ruminant IFNT inhibits NLRP3 inflammasome-driven IL-1β secretion in human macrophages via multiple pathways, including the uptake of nano-silica particles, generation of ROS, and IL-10-mediated inhibition of pro-IL-1β induction. It may be a therapeutic alternative to IFNA and IFNB.
登录
查看更多内容
影响因子:
29.7
作者:
Davis BK;Wen H;Ting JP
通讯作者:
Ting JP
DOI:
10.4161/jkst.23820
发表时间:
2013-01-01
期刊:
JAK-STAT
影响因子:
--
作者:
Rauch I;Müller M;Decker T
通讯作者:
Decker T
影响因子:
4.4
作者:
Soos, JM;Stüve, O;Zamvil, SS
通讯作者:
Zamvil, SS
影响因子:
30.5
作者:
通讯作者:
--
影响因子:
3.8
作者:
Kanno, Sanae;Furuyama, Akiko;Hirano, Seishiro
通讯作者:
Hirano, Seishiro